Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
A series of transactions involving multiple entities associated with Magnetar has resulted in the sale of 349,937 shares of CoreWeave, Inc. (CRWV) Class A Common Stock. The divestment, which took place on May 5, 2026, represents a total capital realization of approximately $44,614,575. The selling entities include Magnetar Financial LLC, Magnetar C…
Entities linked to Magnetar Financial LLC executed a substantial sale of CoreWeave, Inc. (NASDAQ:CRWV) Class A Common Stock on May 5, 2026. The divestment involved the sale of 978,764 shares at weighted average prices ranging between $126.00 and $129.51 per share, resulting in total proceeds of approximately $124.96 million. This transaction follow…
Magnetar Financial LLC, a prominent investment management firm, has executed a notable reduction in its position within CoreWeave, Inc. (NASDAQ: CRWV). On May 4, 2026, the firm and its affiliated entities reported the sale of 420,227 shares of Class A Common Stock. This divestment, totaling approximately $53.5 million, occurred at weighted average …
A series of transactions involving various investment vehicles advised by Magnetar Financial LLC has resulted in the sale of over 1.1 million shares of CoreWeave, Inc. (NASDAQ:CRWV). The divestment, which took place on May 4, 2026, represents a total value of approximately $147,037,492. These sales occurred within a specific price window, reflectin…
RB Global Inc. (NASDAQ:RBA) recently saw insider activity following a period of robust financial performance. Christopher Carlson, serving as the Chief Accounting Officer for the organization, completed a sale of common stock on May 5, 2026. The transaction involved the disposal of 140 shares at a set price of $110.0 per share, resulting in total p…
A recent regulatory filing reveals that Margaret M. Foran, a member of the Board of Directors for Orion Group Holdings Inc. (NASDAQ:ORN), has reduced her position in the company through a common stock sale. The transaction occurred on May 5, 2026, involving 10,695 shares sold at a price point of $15.70 per share. This divestment represents a total …
Vishwas Setia, the Chief Financial Officer of MapLight Therapeutics, Inc. (NASDAQ: MPLT), has completed a sale of company stock totaling more than $1 million. The transaction involved 36,371 shares of common stock and took place over a three-day period from May 4 to May 6, 2026. These sales were conducted through a Rule 10b5-1 trading plan that had…
Sarah Oughtred, the Chief Financial Officer of FIGS, Inc. (NYSE:FIGS), completed a sale of 23,597 shares of the company’s Class A Common Stock on May 4, 2026. The transaction, which comprised several individual trades, resulted in a total value of roughly $338,237. These sales were conducted at a weighted average price of $14.3339 per share, with i…
Heather L. Hasson, the Executive Chairman of FIGS, Inc. (NASDAQ:FIGS), has completed a sale of 32,385 shares of the company's Class A Common Stock. The transaction, which took place on May 4, 2026, resulted in total proceeds of $464,203. According to regulatory filings, these sales were conducted at a weighted average price of $14.3339 per share, w…
Dominic Ng, the Chief Executive Officer of East West Bancorp Inc. (NASDAQ:EWBC), has completed a series of stock sales totaling approximately $3.76 million. These transactions occurred on May 6, 2026, during a period where the company's shares have demonstrated significant upward momentum, trading near their annual highs. The sale took place while …
MapLight Therapeutics (NASDAQ:MPLT) has disclosed a significant insider transaction involving its General Counsel, Kristopher Hanson. On May 4, 2026, Mr. Hanson sold a portion of his holdings in the company's common stock, totaling approximately $388,176. The sale consisted of 13,917 shares, which were liquidated at varying price points between $27…
Erin Pennock Foff, the Chief Medical Officer at MapLight Therapeutics, Inc. (NASDAQ:MPLT), has completed a series of stock sales totaling approximately $1,427,594. The transactions, which occurred between May 4 and May 6, 2026, involved the sale of 50,280 shares of common stock. These disposals were conducted through a Rule 10b5-1 trading plan that…
Lillie James Woodruff, the Chief Scientific Officer at MapLight Therapeutics, Inc. (MPLT), has completed a series of stock sales totaling approximately $1.47 million. The transactions, which involved 51,727 shares of voting common stock, took place between May 4 and May 6, 2026. These sales were conducted under a Rule 10b5-1 trading plan that was e…
Christopher A. Kroeger, the Chief Executive Officer of MapLight Therapeutics, Inc. (NASDAQ:MPLT), has completed a sale of common stock totaling $1,412,235. The transaction involved 49,744 shares and was carried out through a series of trades between May 4 and May 6, 2026. These sales were executed at price points ranging from $27.50 to $30.08 per s…
Nick Khan, serving as a director for TKO Group Holdings, Inc. (NASDAQ:TKO), has completed a sale of company stock totaling approximately $1.77 million. The transactions occurred on May 4, 2026, involving the disposal of 9,518 shares of Class A Common Stock. These sales were executed according to a Rule 10b5-1 trading plan that Mr. Khan had previous…
Roy D. Baynes, a member of the board of directors at Travere Therapeutics, Inc. (NASDAQ: TVTX), has completed a sale of common stock totaling $209,925. The transaction occurred on May 5, 2026, as part of a Rule 10b5-1 trading plan that was established back in November 2025. This movement follows a period of substantial stock performance for Travere…
Jeff Zhou, a member of the board of directors at Monolithic Power Systems Inc. (NASDAQ: MPWR), has completed a series of stock transactions totaling approximately $2.43 million. The sales, which took place over a two-day period in early May 2026, come as the company maintains high momentum following significant year-over-year gains and strong quart…
Travere Therapeutics, Inc. (NASDAQ:TVTX) has seen recent insider activity involving its Chief Commercial Officer, Peter Heerma. Following the successful vesting of performance-based equity units, Mr. Heerma executed a sale of common stock intended specifically to cover tax obligations. This transaction occurs amid a period of significant stock pric…
Christopher R. Cline, the Chief Financial Officer of Travere Therapeutics, Inc. (NASDAQ:TVTX), has completed two separate transactions involving the sale of company common stock. The total value of the shares sold amounted to $115,368, with transaction prices ranging between $43.95 and $46.65 per share. These sales follow a period where the executi…
Eric M. Dube, the Chief Executive Officer of Travere Therapeutics, Inc. (NASDAQ: TVTX), has completed a sale of 22,500 shares of common stock valued at $988,875. The transaction, which occurred on May 6, 2026, was conducted at a price of $43.95 per share. This move followed the vesting of performance-based restricted stock units (PSUs) triggered by…
Todd Krasnow, a director at Symbotic Inc. (NASDAQ:SYM), has completed a sale of company stock totaling $115,217. The transaction was conducted through Inlet View, Inc., an entity where Mr. Krasnow serves as President and CEO, following a structured trading plan established in late 2025. This move comes as the company navigates a period of divergent…
Elizabeth E. Reed, serving as the Chief Legal Officer and General Counsel for Travere Therapeutics, Inc. (NASDAQ:TVTX), has completed a series of stock transactions totaling approximately $1,092,657. These sales took place over a three-day period between May 4 and May 6, 2026. The transaction activity occurs while the company's stock is trading at …
Jeffrey A. Meckler, a director at Travere Therapeutics, Inc. (NASDAQ: TVTX), has completed a sale of company common stock totaling $360,000. The transaction, which took place on May 4, 2026, involved the sale of 8,000 shares at a price point of $45.00 per share. This activity occurred against a backdrop of significant recent price movement for the …
Jula Inrig, the Chief Medical Officer at Travere Therapeutics, Inc. (NASDAQ: TVTX), has completed a series of stock transactions totaling approximately $1,015,085. Between May 4 and May 6, 2026, Ms. Inrig sold a cumulative total of 22,485 shares of the company's common stock. The pricing for these individual sales fluctuated between a low of $43.95…
William E. Rote, serving as the Chief Research Officer for Travere Therapeutics, Inc. (NASDAQ:TVTX), has completed a sale of company common stock totaling $121,433. The transaction, which involved 2,763 shares, occurred at a price point of $43.95 per share. This movement follows a recent acquisition of shares through the vesting of performance-base…
